Connect with us
Information

NORTH AMERICA EDITION
Australia
North America
World

Investing News NetworkYour trusted source for investing success

NORTH AMERICA EDITION
North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

aeglea biotherapeutics

POPULAR ARTICLES

Aeglea BioTherapeutics Doses First Patient in Phase 3 Trial of Pegzilarginase in Arginase 1 Deficiency

NASDAQ:ADAP

Biotech Trends 2018: Immuno-oncology Disappoints

Aeglea BioTherapeutics Announces Design of Pivotal Phase 3 PEACE Trial Evaluating Pegzilarginase in Arginase 1 Deficiency

LATEST ARTICLES

NASDAQ:AGLE

pharmaceutical investing

Aeglea BioTherapeutics Announces Positive Clinical Update

Aeglea BioTherapeutics Announces Positive Interim Clinical Data and Completion of Enrollment for Ongoing Phase 1/2 Trial of Pegzilarginase

Latest News

Equity Metals: Advancing High-grade, District-scale Silver and Gold Assets in British Columbia

South Harz Potash: A Globally Significant European Potash and Critical Minerals Opportunity

Ian Rodger Appointed Managing Director

Terra Clean Energy: Advancing an Expansive Uranium Landholding in the Prolific Athabasca Basin

Athena Gold Closes Private Placement

Outlook Reports

Precious Metals
- Gold
- Silver
Battery Metals
Energy
- Uranium
- Oil and Gas

Base Metals
Critical Metals
- Rare Earths
Industrial Metals
Agriculture

- Cleantech
- Emerging Tech

- Biotech
- Cannabis

- Psychedelics
- Pharmaceuticals

Featured Stocks

South Harz Potash Limited

SHP:AU

Equity Metals

EQTY:CA

Terra Clean Energy

TCEC:CC

NevGold

NAU:CA

FinEx Metals

FINX:CC

Allied Critical Metals

ACM:CC

More featured stocks

Browse Companies

Precious Metals
Battery Metals
Energy

Base Metals
Critical Metals

MARKETS

COMMODITIES

CURRENCIES